Leadership

Transforming Precision Medicine with AI-powered Pathology

Our team’s work is a unique collaboration of experienced AI technologists, physicians and exceptional healthcare research professionals.

Leadership Team

Avi Veidman

CEO, Co-Founder

Lotan Chorev

VP Technology & Operations, Co-founder

Dudi (David) Benayoun

COO

Aviv Levi

Director of Legal and Corporate Operations

Grainger Greene

Head of Product

Elad Amsalem

VP R&D

Ken Bloom, MD, FCAP

Head of Pathology

Hagar Sachs

Head of RA and QA

Ettai Markovits, MD, PhD

Director of Biomedical Research

Dani Zeevi

Director of Strategy

Byron Lawson

VP, Pharma BD & Strategic Partnerships

Board of Directors

Cris De Luca

Sanofi Ventures

Emanuel Timor

Vertex Ventures

Andrew Harrison

Section 32

Noga Yerushalmi

M Ventures

Tom Gibbs

Debiopharm Innovation Fund

Board Observers

Michael Pellini

Section 32

Eyal Ben-Ami

M Ventures

Yuval Dimnik

Fosun RZ Capital

Renana Ashkenazi

Grove Ventures

Antoine Attinger

Debiopharm

Scientific Advisors

Alexander J. Lazar MD, PhD

Pathology Advisor

Suzana Cuoto, PhD

Biopharma Advisor

Julian Adams, PhD

Scientific Advisor

Hossein Borghaei, MD

Medical Advisor

Ester Abels

Regulatory Advisor